期刊
JOURNAL OF CELL SCIENCE
卷 127, 期 6, 页码 1263-1278出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.140087
关键词
TDP-43; ALS; Autophagy; Proteasome; Aggrephagy; UPS
类别
资金
- Wellcome Trust
- Medical Research Council (MRC) [089701]
- American ALS Association
- Psychiatry Research Trust of the Institute of Psychiatry at King's College London
- Wellcome Trust Principal Research Fellow
- European Commission Marie Curie Fellowship [PIIF-GA-2009-252096]
- Medical Research Council [G0900688, MC_G1000733, G1100695, G0501573, G0500289B, G0600974, G0500289, MC_G1000734, G0900635] Funding Source: researchfish
- MRC [G0900635, G1100695, G0600974, G0500289, G0501573, MC_G1000733, G0900688, MC_G1000734] Funding Source: UKRI
TAR DNA-binding protein (TDP-43, also known as TARDBP) is the major pathological protein in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Large TDP-43 aggregates that are decorated with degradation adaptor proteins are seen in the cytoplasm of remaining neurons in ALS and FTD patients post mortem. TDP-43 accumulation and ALS-linked mutations within degradation pathways implicate failed TDP-43 clearance as a primary disease mechanism. Here, we report the differing roles of the ubiquitin proteasome system (UPS) and autophagy in the clearance of TDP-43. We have investigated the effects of inhibitors of the UPS and autophagy on the degradation, localisation and mobility of soluble and insoluble TDP-43. We find that soluble TDP-43 is degraded primarily by the UPS, whereas the clearance of aggregated TDP-43 requires autophagy. Cellular macroaggregates, which recapitulate many of the pathological features of the aggregates in patients, are reversible when both the UPS and autophagy are functional. Their clearance involves the autophagic removal of oligomeric TDP-43. We speculate that, in addition to an age-related decline in pathway activity, a second hit in either the UPS or the autophagy pathway drives the accumulation of TDP-43 in ALS and FTD. Therapies for clearing excess TDP-43 should therefore target a combination of these pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据